CYDY
Price:
$0.12
Market Cap:
$146.38M
CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as coronavirus disease (COVID-19). It is also conducting a Phase 1b/2 clinical trial with leronlimab in metastatic triple-negative breast cancer. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.[Read more]
Industry
Biotechnology
IPO Date
2006-12-13
Stock Exchange
PNK
Ticker
CYDY
According to CytoDyn Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.40. This represents a change of 136.17% compared to the average of 0.17 of the last 4 quarters.
The mean historical Current Ratio of CytoDyn Inc. over the last ten years is 0.69. The current 0.40 Current Ratio has changed 5.66% with respect to the historical average. Over the past ten years (40 quarters), CYDY's Current Ratio was at its highest in in the February 2016 quarter at 3.61. The Current Ratio was at its lowest in in the November 2022 quarter at 0.05.
Average
0.69
Median
0.22
Minimum
0.09
Maximum
3.21
Discovering the peaks and valleys of CytoDyn Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.59%
Maximum Annual Current Ratio = 3.21
Minimum Annual Increase = -92.44%
Minimum Annual Current Ratio = 0.09
Year | Current Ratio | Change |
---|---|---|
2024 | 0.13 | 42.44% |
2023 | 0.09 | -60.95% |
2022 | 0.23 | -72.81% |
2021 | 0.85 | 2.65% |
2020 | 0.83 | 315.00% |
2019 | 0.20 | 0.49% |
2018 | 0.20 | -80.08% |
2017 | 1.00 | -68.97% |
2016 | 3.21 | 1.59% |
2015 | 0.19 | -92.44% |
The current Current Ratio of CytoDyn Inc. (CYDY) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0.15
5-year avg
0.43
10-year avg
0.69
CytoDyn Inc.’s Current Ratio is less than Intercept Pharmaceuticals, Inc. (4.22), less than Madrigal Pharmaceuticals, Inc. (5.98), less than scPharmaceuticals Inc. (8.08), less than Akero Therapeutics, Inc. (17.25), less than Aravive, Inc. (0.98), less than Cardiff Oncology, Inc. (4.74), greater than Reviva Pharmaceuticals Holdings, Inc. (0.39), less than eFFECTOR Therapeutics, Inc. (1.03), less than PDS Biotechnology Corporation (2.84), less than Navidea Biopharmaceuticals, Inc. (0.56),
Company | Current Ratio | Market cap |
---|---|---|
4.22 | $794.69M | |
5.98 | $6.80B | |
8.08 | $169.14M | |
17.25 | $1.99B | |
0.98 | $2.95M | |
4.74 | $260.75M | |
0.39 | $82.91M | |
1.03 | $941.00 | |
2.84 | $61.35M | |
0.56 | $10.01K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CytoDyn Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CytoDyn Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is CytoDyn Inc.'s Current Ratio?
How is the Current Ratio calculated for CytoDyn Inc. (CYDY)?
What is the highest Current Ratio for CytoDyn Inc. (CYDY)?
What is the 3-year average Current Ratio for CytoDyn Inc. (CYDY)?
What is the 5-year average Current Ratio for CytoDyn Inc. (CYDY)?
How does the current Current Ratio for CytoDyn Inc. (CYDY) compare to its historical average?